Search Results 1291-1300 of 25158 for oral

  1. Givinostat (oral route) - Mayo Clinic

    For oral dosage form (suspension):. For Duchenne muscular dystrophy (DMD):. Adults and children 6 years of age and older—Dose is based on body weight and must ...

  2. A Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

  3. A Study to Evaluate the Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...

  4. Folate (folic acid) - Mayo Clinic

    Nutritional folate deficiency is treated with oral folic acid supplements. This type of deficiency is no longer a problem in many countries that fortify foods ...

  5. Phenol (oromucosal route) - Mayo Clinic

    To use the oral rinse or spray: Gargle or spray to the affected area. Let the medicine remain in place for at least 15 seconds, then spit it out. Do not use ...

  6. Azilsartan (oral route) - Mayo Clinic

    For oral dosage form (tablets):. For high blood pressure: Adults—80 milligrams (mg) once a day. Certain patients may need to start with 40 mg once daily ...

  7. Leuprolide and norethindrone (intramuscular route, oral route) - Mayo Clinic

    For oral dosage form (tablets):. For pain due to endometriosis: Adults—5 mg once a day, for up to 6 months. Children—Use is not recommended. Missed Dose. If ...

  8. A Study Comparing Treatment with Oral Solution versus the Standard Intravenous Fluid Therapy for Acute Dehydration in Adults - Mayo Clinic

    The purpose of this study is to compare the efficiency and patient acceptability of treatment with an oral rehydration solution versus the standard intravenous ...

  9. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis - Mayo Clinic

    The primary hypothesis of the study is that treatment with pacritinib results in a greater proportion of patients achieving ≥ 35% reduction in spleen volume ...

  10. An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Clinical Trials · An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma.